Inhibition of in vitro antibody synthesis by cyclophosphamide-induced suppressor cells.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D003520:Cyclophosphamide / Q000494:pharmacology*; D004136:Dinitrobenzenes / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005408:Flagellin / Q000276:immunology; D006736:Horses; D007108:Immune Tolerance; D007700:Kinetics; D051379:Mice; D008808:Mice, Inbred CBA; D012756:Sheep; D013154:Spleen / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D013997:Time Factors
D004136:Dinitrobenzenes; D005408:Flagellin; D003520:Cyclophosphamide